AGREEMENTSchedule 13d Filing • November 8th, 2011 • Tisch Thomas J • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this statement on Schedule 13D dated November 7, 2011 relating to the Common Stock of Synageva BioPharma Corp. is being filed with the Securities and Exchange Commission on behalf of each of them.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 10th, 2001 • Tisch Thomas J • Office machines, nec • Connecticut
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of November 28, 2001 (the “Effective Date”) by and between Gunther International Ltd., a Delaware corporation (the “Company”), and Gunther Partners, LLC, a Delaware limited liability company (“Gunther Partners”). Except as otherwise indicated herein, capitalized terms used herein are defined in Article VII hereof.
AGREEMENTSchedule 13d Filing Agreement • October 14th, 2003 • Tisch Thomas J • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, par value $.001 per share, of IntraBiotics Pharmaceuticals, Inc., and such other amendments as may be filed by them hereafter, are being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTAmendment No. 7 to Schedule 13d • July 11th, 2001 • Tisch Thomas J • Office machines, nec
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Amendment No. 7 to Schedule 13D relating to the Common Stock, $0.001 par value per share, of Gunther International, Ltd., as the same may be amended from time to time hereafter, is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • February 7th, 2002 • Tisch Thomas J • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, par value $0.001 per share, of Trimeris, Inc., and such other amendments as may be filed by them hereafter, are being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTSchedule 13d Agreement • June 6th, 2003 • Tisch Thomas J • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, par value $.001 per share, of IntraBiotics Pharmaceuticals, Inc., and such other amendments as may be filed by them hereafter, are being filed with the Securities and Exchange Commission on behalf of each of them.
GUNTHER INTERNATIONAL LTD. One Winnenden Road Norwich, CT 06360-1570 November 28, 2001Termination of Voting Agreement • December 10th, 2001 • Tisch Thomas J • Office machines, nec
Reference is made to that certain voting agreement by and between Gunther International Ltd. (the "Company"), Gunther Partners, LLC ("Gunther Partners"), Park Investment Partners, Inc., the Estate of Harold S. Geneen, Four Partners and Robert Spiegel dated as of October 2, 1998.
